Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/19/2019 | Entasis Therapeutics Holdings Inc. | ETTX | Grant | Stock Option (Right to Buy) | 7.5k | $6.12 | $45.9k | | 06/19/2019 |
03/25/2019 | NanoString Technologies Inc | NSTG | Grant | Common Stock | 4.4k | $23.34 | $102.9k | | 03/25/2019 |
01/18/2019 | Entasis Therapeutics Holdings Inc. | ETTX | Grant | Stock Option (right to buy) | 15k | $5.66 | $84.9k | | 01/18/2019 |
09/28/2018 | Entasis Therapeutics Holdings Inc. | ETTX | Conversion | Common Stock | 361.8k | $0.00 | $0 | See Footnote | 09/28/2018 |
09/28/2018 | Entasis Therapeutics Holdings Inc. | ETTX | Conversion | Common Stock | 323.3k | $0.00 | $0 | See Footnote | 09/28/2018 |
09/28/2018 | Entasis Therapeutics Holdings Inc. | ETTX | Conversion | Common Stock | 412.6k | $0.00 | $0 | See Footnote | 09/28/2018 |
09/28/2018 | Entasis Therapeutics Holdings Inc. | ETTX | Purchase | Common Stock | 453.4k | $15.00 | $6.8M | See Footnote | 09/28/2018 |
09/28/2018 | Entasis Therapeutics Holdings Inc. | ETTX | Conversion | Series B Convertible Preferred Stock | 7.5M | $0.00 | $0 | See Footnote | 09/28/2018 |
09/28/2018 | Entasis Therapeutics Holdings Inc. | ETTX | Conversion | Series B-1 Tranche A Convertible Preferred Stock | 6.7M | $0.00 | $0 | See Footnote | 09/28/2018 |
09/28/2018 | Entasis Therapeutics Holdings Inc. | ETTX | Conversion | Series B-1 Tranche B Convertible Preferred Stock | 8.6M | $0.00 | $0 | See Footnote | 09/28/2018 |
09/17/2018 | NanoString Technologies Inc | NSTG | Exercise (in-the-money or at-the-money) | Common Stock Warrant (Right to Buy) | 162.4k | $8.45 | $1.4M | See footnotes | 09/17/2018 |
09/17/2018 | NanoString Technologies Inc | NSTG | Sale | Common Stock | 85.8k | $15.99 | $1.4M | See footnotes | 09/17/2018 |
01/01/2018 | NanoString Technologies Inc | NSTG | Grant | Common Stock | 10.2k | $7.47 | $76k | | 01/01/2018 |
01/01/2017 | NanoString Technologies Inc | NSTG | Grant | Stock Option (Right to Buy) | 8.6k | $22.30 | $192k | | 01/01/2017 |
08/03/2016 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 6.5k | $4.55 | $29.6k | | 08/03/2016 |
01/11/2016 | IVERIC bio, Inc. | OPHT | Sale | Common Stock | 999 | $65.45 | $65.4k | | 01/11/2016 |
01/11/2016 | IVERIC bio, Inc. | OPHT | Sale | Common Stock | 1k | $66.33 | $66.4k | | 01/11/2016 |
01/11/2016 | IVERIC bio, Inc. | OPHT | Sale | Common Stock | 501 | $65.45 | $32.8k | See Footnote | 01/11/2016 |
01/11/2016 | IVERIC bio, Inc. | OPHT | Sale | Common Stock | 499 | $65.33 | $32.6k | See Footnote | 01/11/2016 |
01/01/2016 | NanoString Technologies Inc | NSTG | Grant | Stock Option (Right to Buy) | 7.8k | $14.71 | $115.1k | | 01/01/2016 |
12/10/2015 | IVERIC bio, Inc. | OPHT | Sale | Common Stock | 533 | $63.90 | $34.1k | | 12/10/2015 |
12/10/2015 | IVERIC bio, Inc. | OPHT | Sale | Common Stock | 1.5k | $64.63 | $94.8k | | 12/10/2015 |
12/10/2015 | IVERIC bio, Inc. | OPHT | Sale | Common Stock | 267 | $63.91 | $17.1k | See Footnote | 12/10/2015 |
12/10/2015 | IVERIC bio, Inc. | OPHT | Sale | Common Stock | 733 | $64.63 | $47.4k | See Footnote | 12/10/2015 |
11/18/2015 | IVERIC bio, Inc. | OPHT | Sale | Common Stock | 1000 | $60.00 | $60k | | 11/18/2015 |
11/18/2015 | IVERIC bio, Inc. | OPHT | Sale | Common Stock | 500 | $60.00 | $30k | See Footnote | 11/18/2015 |
11/10/2015 | IVERIC bio, Inc. | OPHT | Sale | Common Stock | 1000 | $58.69 | $58.7k | | 11/09/2015 |
11/10/2015 | IVERIC bio, Inc. | OPHT | Sale | Common Stock | 500 | $58.69 | $29.3k | See Footnote | 11/09/2015 |
11/09/2015 | IVERIC bio, Inc. | OPHT | Sale | Common Stock | 1000 | $60.00 | $60k | | 11/09/2015 |
11/09/2015 | IVERIC bio, Inc. | OPHT | Sale | Common Stock | 500 | $60.00 | $30k | See Footnote | 11/09/2015 |
11/02/2015 | IVERIC bio, Inc. | OPHT | Sale | Common Stock | 1000 | $54.00 | $54k | | 11/02/2015 |
11/02/2015 | IVERIC bio, Inc. | OPHT | Sale | Common Stock | 500 | $54.00 | $27k | See Footnote | 11/02/2015 |
06/30/2015 | Astria Therapeutics, Inc. | ATXS | Conversion | Common Stock | 1.6M | $0.00 | $0 | See Footnotes | 06/30/2015 |
06/30/2015 | Astria Therapeutics, Inc. | ATXS | Conversion | Common Stock | 757.1k | $0.00 | $0 | See Footnotes | 06/30/2015 |
06/30/2015 | Astria Therapeutics, Inc. | ATXS | Purchase | Common Stock | 376.7k | $12.00 | $4.5M | See Footnotes | 06/30/2015 |
|